SEARCH

SEARCH BY CITATION

References

  • 1
    Younossi ZM, Guyatt G. Quality of life assessments and chronic liver disease. Am J Gastroenterol 1998;93:103741.
    Direct Link:
  • 2
    Ratcliffe J, Longworth L, Young T, et al. Assessing health-related quality of life pre-and post-liver transplantation: a prospective multicenter study. Liver Transpl 2002;8:26370.
  • 3
    Younossi ZM, McCormick M, Price LL, et al. Impact of liver transplantation on health-related quality of life. Liver Transpl 2000;6:77983.
  • 4
    Casanovas T, Ramos E, Menchón JM, et al. Changes in quality of life after liver transplant. Impact of hepatitis C virus infection. Hepatology 1998;28:A278.
  • 5
    Martin LM, Dan AA, Younossi ZM. Measurement of health-related quality of life in patients with chronic liver disease. Liver Transpl 2006;12:223.
  • 6
    Tome S, Wells JT, Said A, Lucey MR. Quality of life after liver transplantation. A systematic review. J Hepatol 2008;48:56777.
  • 7
    Gralnek I, Hays RD, Kilbourne A, et al. Development and evaluation of the liver disease quality of life instrument in persons with advanced chronic liver disease––The LDQOL 1.0. Am J Gastroenterol 2000;95:355265.
  • 8
    Younossi ZM, Guyatt G, Kiwi M, et al. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut 1999;45:295300.
  • 9
    Bayliss MS, Gandek B, Bungay KM, et al. A questionnaire to assess the generic and disease-specific health outcomes of patients with chronic hepatitis C. Qual Life Res 1998;7:3955.
  • 10
    Kanwal F, Spiegel BM, Hays RD, et al. Prospective validation of the short form liver disease quality of life instrument. Aliment Pharmacol Ther 2008;28:1088101.
  • 11
    Kanwal F, Gralnek IM, Hays RD, et al. Health-related quality of life predicts mortality in patients with advanced chronic liver disease. Clin Gastroenterol Hepatol 2009;7:7939.
  • 12
    Casanovas T, Vallejo G, Herdman M, et al. Validation of the Spanish version of the liver disease quality of life questionnaire in transplant patients. Transplant Proc 2003;35:18035.
  • 13
    Herdman M, Fox-Rushby J, Badía X. A model of equivalence in the cultural adaptation of HRQoL instruments: the universalist approach. Qual Life Res 1998;7:32335.
  • 14
    Deyo RA. Pitfalls in measuring the health status of Mexican Americans: comparative validity of the English and Spanish sickness impact profile. Am J Public Health 1984;74:56973.
  • 15
    Kanwal F, Hays RD, Kilbourne AM, et al. Are physician-derived disease severity indices associated with health-related quality of life in patients with end-stage liver disease? Am J Gastroenterol 2004;99:172632.
    Direct Link:
  • 16
    Ware JE Jr, Kosinski M, Dewey JE. How to Score Version 2 of the SF-36 Health Survey. Lincoln, RI: QualityMetric, 2000.
  • 17
    Casanovas Taltavull T, Vallejo Blanxart G, Herdman M, et al. Adaptación transcultural del cuestionario específico de calidad de vida para hepatopatías crónicas (LDQOL 1.0) para su uso en la población Española. Gastroenterol Hepatol 2003;26:23444.
  • 18
    Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed measures. J Clin Epidemiol 1993;46:141732.
  • 19
    Alonso J, Prieto L, Antó JM. La versión española del SF-36 Health Survey (Cuestionario de Salud SF-36): un instrumento para la medida de los resultados clínicos. Med Clin (Barc) 1995;104:7716.
  • 20
    Brown RS Jr, Kumar KS, Russo MW, et al. Model for end-stage liver disease and Child–Turcotte–Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients. Liver Transpl 2002;8:27884.
  • 21
    Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:46470.
  • 22
    Hays RD, Anderson R, Revicki D. Psychometric considerations in evaluating health-related quality of life measures. Qual Life Res 1993;2:4419.
  • 23
    Kondo Y, Yoshida H, Tateishi R, et al. Health-related quality of life of chronic liver disease patients with and without hepatocellular carcinoma. J Gastroenterol Hepatol 2007;22:197203.
  • 24
    Iacobucci D, Duhachek A. Advancing alpha: measuring reliability with confidence. J Consum Psychol 2003;13:47887.
  • 25
    Campbell DT, Fiske DW. Convergent and discriminant validation by the multitrait–multimethod matrix. Psychol Bull 1959;56:81105.
  • 26
    Ferrer M, Córdoba J, Garin O, et al. Validity of the Spanish version of the Chronic Liver Disease Questionnaire (CLDQ) as a standard outcome for quality of life assessment. Liver Transpl 2006;12:95104.
  • 27
    Bach N, Schaffner F, Kapelman B. Sexual behavior in women with nonalcoholic liver disease. Hepatology 1989;9:698703.
  • 28
    Scientific Advisory Comittee of the Medical Outcomes Trust. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 2002;11:193205.
  • 29
    Saab S, Ibrahim AB, Shpaner A, et al. MELD fails to measure quality of life in liver transplant candidates. Liver Transpl 2005;11:21823.
  • 30
    Van Der Plas SM, Hansen BE, De Boer JB, et al. Generic and disease-specific health related quality of life of liver patients with various aetiologies: a survey. Qual Life Res 2007;16:37588.
  • 31
    Kallman J, O'neil MM, Larive B, et al. Fatigue and health-related quality of life (HRQL) in chronic hepatitis C virus infection. Dig Dis Sci 2007;52:25319.
  • 32
    Dias Teixeira MC, De Fatima Gomes de Sa Ribeiro M, Strauss E. A new insight into the differences among non-cirrhotic and cirrhotic patients using the liver disease quality of life instrument (LDQOL). Ann Hepatol 2005;4:26471.
  • 33
    Zifroni A, Schiavi RC, Schaffner F. Sexual function and testosterone levels in men with nonalcoholic liver disease. Hepatology 1991;14:47982.
  • 34
    Gomez-Lobo V, Burgansky A, Kim-Schluger L, Berkowitz R. Gynecologic symptoms and sexual function before and after liver transplantation. J Reprod Med 2006;51:45762.
  • 35
    Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989;10:40715.
  • 36
    Figueras J, Jaurrieta E, Valls C, et al. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. Hepatology 1997;25:14859.
  • 37
    FayersP, MachinD, eds. Quality of Life: The Assessment, Analysis, and Interpretation of Patient-reported Outcomes. Chichester: Wiley, 2007.